Published in Genes Dev on May 01, 2011
Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci (2012) 1.76
Conserved RB functions in development and tumor suppression. Protein Cell (2011) 1.15
The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Cell Death Differ (2013) 1.04
The role of the hippo pathway in melanocytes and melanoma. Front Oncol (2013) 0.90
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The regulation of E2F by pRB-family proteins. Genes Dev (1998) 12.77
The hippo signaling pathway in development and cancer. Dev Cell (2010) 10.54
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev (2010) 6.05
The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer (2002) 4.48
pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev (1997) 4.36
Extra-embryonic function of Rb is essential for embryonic development and viability. Nature (2003) 3.92
Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol (2008) 3.81
YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev (2008) 3.16
Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell (2004) 2.89
Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell (2007) 2.74
Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev (2004) 2.73
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J (1994) 2.57
Upstream regulation of the hippo size control pathway. Curr Biol (2010) 2.09
Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol (1999) 1.97
DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev (2011) 1.82
DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J (2010) 1.55
MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J (2010) 1.36
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev (2011) 1.30
The role of DYRK1A in neurodegenerative diseases. FEBS J (2010) 1.23
Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit. Genes Dev (2011) 1.13
Combined inactivation of pRB and hippo pathways induces dedifferentiation in the Drosophila retina. PLoS Genet (2010) 1.10
G1 arrest and differentiation can occur independently of Rb family function. J Cell Biol (2010) 1.02
New molecular tools for efficient screening of cervical cancer. Dis Markers (2001) 0.96
Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol (2002) 2.27
Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol (2008) 1.53
Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J Cell Sci (2003) 1.45
Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene (2003) 1.36
Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene (2003) 1.24
Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. Small (2011) 1.22
E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem (2004) 1.14
Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. J Virol (2005) 1.08
Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Lab Invest (2011) 1.07
Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide. Int J Cancer (2005) 1.06
Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses. J Virol (2002) 1.05
Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head Neck (2011) 1.02
Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP. Nucleic Acids Res (2009) 1.01
Roles for APIS and the 20S proteasome in adenovirus E1A-dependent transcription. EMBO J (2006) 1.01
The coactivator p/CIP/SRC-3 facilitates retinoic acid receptor signaling via recruitment of GCN5. J Biol Chem (2003) 0.98
A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing. ISRN Oncol (2012) 0.97
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Identification of a second CtBP binding site in adenovirus type 5 E1A conserved region 3. J Virol (2008) 0.96
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg (2013) 0.95
Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg (2013) 0.94
Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines. Arch Otolaryngol Head Neck Surg (2012) 0.93
Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor. Mol Endocrinol (2003) 0.92
The adenovirus E1A protein targets the SAGA but not the ADA transcriptional regulatory complex through multiple independent domains. J Biol Chem (2002) 0.91
Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1. Virology (2011) 0.90
Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy. Cancer Res (2004) 0.89
Identification of a second independent binding site for the pCAF acetyltransferase in adenovirus E1A. Virology (2009) 0.89
E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode. Proc Natl Acad Sci U S A (2005) 0.89
Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin. J Neurooncol (2005) 0.89
Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation. J Virol (2011) 0.89
The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression. J Biol Chem (2004) 0.87
Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor. J Virol (2012) 0.87
Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation. J Virol (2012) 0.86
An improved genetic system for detection and analysis of protein nuclear import signals. BMC Mol Biol (2007) 0.85
The C-terminal region of E1A: a molecular tool for cellular cartography. Biochem Cell Biol (2012) 0.84
Adenovirus E1A directly targets the E2F/DP-1 complex. J Virol (2011) 0.84
The E1A proteins of all six human adenovirus subgroups target the p300/CBP acetyltransferases and the SAGA transcriptional regulatory complex. Virology (2003) 0.84
Analysis of DNA binding by the adenovirus type 5 E1A oncoprotein. J Gen Virol (2002) 0.83
Comparison of E1A CR3-dependent transcriptional activation across six different human adenovirus subgroups. J Virol (2010) 0.82
Viral retasking of hBre1/RNF20 to recruit hPaf1 for transcriptional activation. PLoS Pathog (2013) 0.81
Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variants. Nucl Recept Signal (2006) 0.81
Ki-67 expression predicts radiotherapy failure in early glottic cancer. J Otolaryngol Head Neck Surg (2012) 0.81
The adenoviral E1A protein displaces corepressors and relieves gene repression by unliganded thyroid hormone receptors in vivo. Cell Res (2009) 0.81
Coactivator requirements for p53-dependent transcription in the yeast Saccharomyces cerevisiae. Int J Cancer (2008) 0.80
Characterization of the 55-residue protein encoded by the 9S E1A mRNA of species C adenovirus. J Virol (2012) 0.79
Requirements for E1A dependent transcription in the yeast Saccharomyces cerevisiae. BMC Mol Biol (2009) 0.79
Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines. Intervirology (2013) 0.78
The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function. J Virol (2014) 0.78
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases. Case Rep Oncol Med (2013) 0.77
New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation. J Virol Methods (2002) 0.76
Adenovirus E1A recruits the human Paf1 complex to enhance transcriptional elongation. J Virol (2014) 0.76
An unhealthy relationship: viral manipulation of the nuclear receptor superfamily. Future Microbiol (2011) 0.76
The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptor. J Gen Virol (2013) 0.75
Accumulation of p53 in response to adenovirus early region 1A sensitizes human cells to tumor necrosis factor alpha-induced apoptosis. Virology (2005) 0.75